It’s a short leisurely walk to the Institute of Psychiatry, a world leader in research into the treatment of mental illness. It’s here that we get the chance to hear about the drug Largactyl in a bit more depth. Fellow walkers are encouraged to share their knowledge and we are lucky enough have Peter Nicol, a former psychiatric nurse, in our midst. Nicol describes how the drug Largactyl was prescribed routinely. “When I first started working in psychiatric hospitals in the 1950s, we used to give Largactyl to patients, which produced the unfortunate side-effect of a shuffling walk,” he says.
More from Community Care
Related articles:
Featured jobs
Workforce Insights
- Working with perpetrators of domestic abuse: training social workers to have challenging conversations
- Extending support: the importance of reflective supervision beyond the ASYE
- ‘It’s hopeful work’: social work in an adults’ mental health team
- Podcast: supporting adults with learning disabilities and autism post-pandemic
- ‘There aren’t many roles where you get to take a child on holiday’: the benefits of residential care work
- Workforce Insights – showcasing a selection of the sector’s top recruiters
Community Care Inform
Latest stories
Regulator calls for consistency of support for NQSWs as DfE develops children’s early career framework
Leadership training programme launched for PSWs, AMHP leads and principal OTs in adults’ services
Kent ‘extremely close to capacity’ to care for unaccompanied asylum-seeking children
Frisbee Crockery: a girl’s journey from abusive home to safety in care
Comments are closed.